Fig. 4From: Can low-dose intravenous immunoglobulin be an alternative to high-dose intravenous immunoglobulin in the treatment of children with newly diagnosed immune thrombocytopenia: a systematic review and meta-analysisForrest plot of the pooled effective rate in the HD-IVIg groupBack to article page